Metformin is a drug of choice in all existing recommendations of the management of type 2 diabetes today. The number of patients receiving metformin progressively increasing day by day. This article describes the cellular and molecular mechanisms of action of metformin,

Aims : In search of add - on treatments to metformin , sodium - glucose cotransporter -2 ( SGLT -2) inhibitors are potential candidates . This meta-analysis examines the potential use of SGLT-2 inhibitors in combination with metformin as a therapeutic option for type 2

Despite advances in treatment for type 2 diabetes in recent decades, many patients are failing to achieve adequate glycemic control. Poor glycemic control has been shown to have a detrimental effect on patients’ health and well-being, and to have significant negative

Materials publications are designed to help clinicians in differential diagnosis of forms of diabetic foot syndrome. Separation of patients with diabetic foot syndrome in the group on the basis of neuropathy, angiopathy or osteoarthropathy when doctor met the patient first

The article presents the results of evaluation of effect of taurine in the combined treatment of patients with diabetes mellitus type 2 and chronic heart failure on carbohydrate and lipid metabolism, insulin resistance, functional state of the liver during th e 16 week study

This article analyses the results of application o f Reduxine (sibutramin) in a combination with metformin (Sibutramine-metformin Combination) as a part of th e All-Russia Non-interventional Program of Reduxin e Safety Monitoring for Weight Reduction in Patient s With